Publications in collaboration with researchers from Hospital de Cruces (18)

2024

  1. Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease

    npj Parkinson's Disease, Vol. 10, Núm. 1

2022

  1. Potential Tear Biomarkers for the Diagnosis of Parkinson’s Disease—A Pilot Study

    Proteomes, Vol. 10, Núm. 1

2021

  1. Recommendations for ophthalmologic practice during the easing of COVID-19 control measures

    Acta Ophthalmologica, Vol. 99, Núm. 7, pp. e973-e983

2020

  1. Changes in the corneal thickness and limbus after 1 year of scleral contact lens use

    Eye (Basingstoke), Vol. 34, Núm. 9, pp. 1654-1661

2018

  1. Dexamethasone protects retinal ganglion cells but not Müller glia against hyperglycemia in vitro

    PLoS ONE, Vol. 13, Núm. 11

  2. Efficacy and safety of an aflibercept treat-and-extend regimen in treatment-naïve patients with macular oedema secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial

    Journal of Ophthalmology, Vol. 2018

2017

  1. Effect of hypoxia on the retina and superior colliculus of neonatal pigs

    PLoS ONE, Vol. 12, Núm. 4

2014

  1. Human tear peptide/protein profiling study of ocular surface diseases by SPE-MALDI-TOF mass spectrometry analyses

    EuPA Open Proteomics, Vol. 3, pp. 206-215

2013

  1. Neuroprotective effects of topical CB1 agonist WIN 55212-2 on retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat

    Experimental Eye Research, Vol. 110, pp. 55-58

  2. Novel molecular diagnostic system of limbal stem cell deficiency based on MUC5AC transcript detection in corneal epithelium by PCR-reverse dot blot

    Investigative Ophthalmology and Visual Science, Vol. 54, Núm. 8, pp. 5643-5652

  3. Tear proteome and protein network analyses reveal a novel pentamarker panel for tear film characterization in dry eye and meibomian gland dysfunction

    Journal of Proteomics, Vol. 78, pp. 94-112

2012

  1. Comparative study of limbal stem cell deficiency diagnosis methods: Detection of MUC5AC mRNA and goblet cells in corneal epithelium

    Ophthalmology, Vol. 119, Núm. 5, pp. 923-929

  2. Effect of synthetic cannabinoid CB1 agonist (WIN 55212-2) and antagonist (AM 251) on intraocular pressure in rats

    Glaucoma: Etiology, Pathogenesis and Treatments (Nova Science Publishers, Inc.), pp. 147-156

  3. In vitro effects of three blood derivatives on human corneal epithelial cells

    Investigative Ophthalmology and Visual Science, Vol. 53, Núm. 9, pp. 5571-5578

2011

  1. Current trends in glaucoma: What's about neuroprotection?

    Advances in Medicine and Biology (Nova Science Publishers, Inc.), pp. 149-174

  2. Prevention of retinal ganglion cell swelling by systemic brimonidine in a rat experimental glaucoma model

    Clinical and Experimental Ophthalmology, Vol. 39, Núm. 8, pp. 799-807

2010

  1. Optic neuropathy in methylmalonic acidemia: The role of neuroprotection

    Journal of Inherited Metabolic Disease, Vol. 33, Núm. SUPPL. 3

  2. Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects

    Cornea, Vol. 29, Núm. 8, pp. 843-848